Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지

THE CLINICAL SIGNIFICANCE OF THE EXPRESSION OF TGF-${\beta}1$ AND MMP-2 RELATED TO THE REGIONAL LYMPH NODE METASTASIS IN THE ORAL SQUAMOUS CELL CARCINOMA

구강 편평 상피 암종에서 TGF-${\beta}1$과 MMP-2의 발현과 경부 임파절 전이 간의 상관 관계에 관한 연구

  • Kim, Jwa-Young (Department of Oral and Maxillofacial Surgery, Sacred Heart Hospital, Hallym University) ;
  • Rotaru, Horatiu (Department of Craniomaxillofacial Surgery, "Iuliu Hatieganu" University of Medicine and Pharmacy) ;
  • Kim, Seong-Gon (Department of Oral and Maxillofacial Surgery, Sacred Heart Hospital, Hallym University)
  • 김좌영 (한림대학교 성심병원 구강악안면외과) ;
  • ;
  • 김성곤 (한림대학교 성심병원 구강악안면외과)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Several matrix metalloproteinases (MMPs) have been shown to play an important role in the invasion and metastasis of oral squamous cell carcinoma (OSCC). The members of the TGF-$\beta$ signaling pathway are being considered as predictive biomarkers for progressive tumorigenesis and molecular targets for the prevention and the treatment of cancer and metastasis. The aim of the present study was to find the clinical significance of the expression of TGF-${\beta}1$ and MMP-2 related to the regional lymph node metastasis in OSCC. This study included 76 cases of primary OSCC, of which 42 cases showed regional lymph node metastases. Immunohistochemistry was used for the localization of protein. The relation between the expression of each protein and clinical variables was statistically evaluated. In results, the expression of TGF-${\beta}1$ both main mass with lymph node metastasis and without lymph node metastasis was found not to be statistically significant (p>0.05). The expression of MMP-2 was found to be statistically significant related to regional lymph node metastasis (p<0.05). When compared the expression in the metastatic lymph node, TGF-${\beta}1$ was significantly highly expressed than MMP-2 (p<0.05). In conclusion, the expression of MMP-2 was significantly elevated in patients with lymph node metastasis as compared to the patients without lymph node metastasis, which could be useful in predicting the risk of lymph node metastasis in OSCC.

Keywords

References

  1. Dang D, Yang Y, Li X, Atakilit A, Regezi J, Eiseke D, et al: Matrix metalloproteinases and TGF- beta1 modulate oral tumor cell matrix. Biochem Biophys Res Commun 2004;316:937-942 https://doi.org/10.1016/j.bbrc.2004.02.143
  2. Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41:184-197 https://doi.org/10.1002/ijc.2910410205
  3. Gorogh T, Beier UH, Baumken J, Meyer JE, Hoffmann M, Gottschlich S, et al: Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas. HEAD NECK 2006;28:31-39 https://doi.org/10.1002/hed.20298
  4. Sier CFM, Kubben FJGM, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, et al: Tissue level of matrix maetalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996;74:413-417 https://doi.org/10.1038/bjc.1996.374
  5. Hong SD, Hong SP, Lee JI, Lim CY: Expression of matrix metalloproteinase- 2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 2000;36:207-213 https://doi.org/10.1016/S1368-8375(99)00088-3
  6. Graesslin O, Cortez A, Uzan C, Birembaut P, Quereux C, Darai E: Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer 2006;16:1911-1917 https://doi.org/10.1111/j.1525-1438.2006.00717.x
  7. Kylmaniemi M, Oikarinen A, Oikarinen K, Salo T: Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells. J Dent Res 1996;75:919-926 https://doi.org/10.1177/00220345960750030901
  8. Yoshizaki T, Maruyama Y, Sato H, Furukawa M: Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 2001;95:44-50 https://doi.org/10.1002/1097-0215(20010120)95:1<44::AID-IJC1008>3.0.CO;2-M
  9. Li Q, Zhou XJ, Zhang ZY, Patima, Chen WT: Evaluation of TGFbeta1 expressed by oral and maxillofacial malignant neoplasm. Shanghai Kou Qiang Yi Xue 2002;11:233-236
  10. Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW, Chatterjee SK: Tumor metastasis in an orthotopic murine model of head and neck cancer:possible role of TGF-beta1 secreated by the tumor cells. J Cell Biochem 2006;1:1036-1051
  11. Paterson IC, MAttews JB, Huntley S, Robinson CM, Fahey M, Parkinson EK, et al: Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma. J Pathol 2001;193:458-467 https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH822>3.0.CO;2-V
  12. Nakagawa T, Kubota T, Kabuto M, fujimoto N, Okada Y: Secretion of matrixmetalloprotinase-2 (72 kDa gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix. J Neurooncol 1996;28:13-24 https://doi.org/10.1007/BF00300442
  13. Lengyel E, Gum R, Juarez J, Clayman G, Seiki M, Sato H, et al : Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res 1995; 55:963-967
  14. Patel BP, Shah PM, Rawal UM, Desai AA, Shah SV, Rawal RM, et al: Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 2005;90:81-88 https://doi.org/10.1002/jso.20240
  15. Tokumaru Y, Fujii M, Otani Y, Kameyama K, Imanishi Y, Igarashi N, et al: Activation of matrixmetalloproteinase-2 in head and neck squamous cell carcinoma:Studies of clinical sample and in vitro cell lines co-cultured with fibroblasts. Cancer Lett 2000;150:15-21 https://doi.org/10.1016/S0304-3835(99)00371-7
  16. Sutinene M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, et al.: Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors(TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamouscell carcinoma and lymph node metastasis. Br J Cancer 1998;77:2239-2245 https://doi.org/10.1038/bjc.1998.372
  17. Liu LK, Li YN, Jiang HB, He ZX, Yi XZ : The correlation between neck lymph node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cellcarcinomas. Hua Xi Kou Qiang Yi Xue Za Zhi 2004;22:106-108
  18. Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, et al : Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis. Clin Cancer Res 2004;10:634-640 https://doi.org/10.1158/1078-0432.CCR-0864-02
  19. Kato K, Hara A, Kuno T, Kitaori N, Huilan Z, Mori H, et al: Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol 2005;131:340-346 https://doi.org/10.1007/s00432-004-0654-8
  20. Jin X, Li J, Li z, Li Y: Expresion of transforming growth factor beta (TGF-beta) subtypes in oral squamous cell carcinoma. Hua Xi Kou Qiang Yi Xue Za Zhi 2001;19:377-379